Med BioGene - Publications

Featured News

September 04, 2014

Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting

August 29, 2014

Med BioGene Reports Financial Results for Q2 2014

August 21, 2014

Med BioGene Responds to Assertions Made by Dissident Shareholder

August 15, 2014

Med BioGene Provides Update and Announces Proposed Financing

August 06, 2014

Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting

March 24, 2014

Med BioGene Announces Regulatory Approval of GeneFx® Lung

Home	Publications

Publications

Title	Journal / Meeting	Year
Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non-Small-Cell Lung Cancer Including Stage IA Patients (click here)	Journal of Thoracic Oncology	2014
Performance of a Prognostic Genomic Signature for Early-Stage NSCLC in Matched Fresh Frozen and RNA-Stabilized Tissue (click here)	Annual Meeting of the American Society of Clinical Oncology	2013
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer (click here) Editorial (click here)	Journal of Clinical Oncology	2010
Validation of a Prognostic Gene Signature for Early-Stage Non-Small-Cell Lung Cancer in an Independent Cohort (click here)	American Association for Cancer Research – International Association for the Study of Lung Cancer Joint Conference on Molecular Origins of Lung Cancer	2010
Initial Evaluation of the Health Economic Impact of a Prognostic 15-gene Expression-based Signature in Early-Stage NSCLC Patient Management (click here )	American Association for Cancer Research – International Association for the Study of Lung Cancer Joint Conference on Molecular Origins of Lung Cancer	2010
A 15-gene Expression Signature Prognostic for Survival and Predictive for Adjuvant Chemotherapy Benefit in JBR.10 Patients (click here)	Annual Meeting of the American Society of Clinical Oncology	2008